People | Critical Path Institute

Home>About>People

Leadership Team
Board of Directors
Advisors to the Board

Leadership Team

Full profile
Lewis Barbieri, JD
Director, Contracts, Legal Services, and Compliance
Full profile
Martha A. Brumfield, PhD
Special Advisor, Former President and CEO
Full profile
Jackson Burton, PhD
Executive Director, Quantitative Medicine Program
Full profile
Stephen Joel Coons, PhD
Program Officer, Clinical Outcome Assessment Program; Executive Director, Patient-Reported Outcome Consortium
Full profile
Graham Higson, M.Sc.
Executive Director of European Office
Full profile
Jane Larkindale, DPhil
Executive Director, Duchenne Regulatory Sciences Consortium; Executive Director, Rare Disease Cures Accelerator-Data and Analytics Platform
Full profile
Rick Liwski
Chief Technology Officer and Director, Data Collaboration Center
Full profile
Inish O’Doherty, PhD
Executive Director, Transplant Therapeutics Consortium; Executive Director, Type 1 Diabetes Consortium
Full profile
Klaus Romero, MD, MS
Chief Science Officer; Executive Director of Clinical Pharmacology
Full profile
John-Michael Sauer, PhD
Program Officer, Biomarker Programs; Executive Director, Predictive Safety Testing Consortium
Full profile
Joseph Scheeren, PharmD
President and CEO
Full profile
Marco Schito, PhD
Executive Director, CURE Drug Repurposing Collaboratory
Full profile
Kanwaljit Singh, MD, MPH
Executive Director, International Neonatal Consortium
Full profile
Sudhir Sivakumaran, PhD
Executive Director, Critical Path for Alzheimer's Disease Consortium, Interim Executive Director, Huntington's Disease Regulatory Science Consortium
Full profile
Diane Stephenson, PhD
Executive Director, Critical Path for Parkinson's Consortium
Full profile
Kristen Swingle, MS
Chief Operating Officer
Full profile
Raymond Woosley, MD, PhD
Founder and Former CEO, Current Senior Advisor

Board of Directors

Advisors to the Board

x